Literature DB >> 15518369

In-vitro activity of nitrofurantoin in enterococcus urinary tract infection.

T Butt1, M J Leghari, A Mahmood.   

Abstract

OBJECTIVE: To compare in-vitro antimicrobial susceptibility of nitrofurantoin against commonly used antimicrobials for the treatment of urinary tract infection caused by enterococci.
METHODS: A total of 144 enterococci (Enterococcus faecalis, n=130, Enterococcus faecium, n=14) isolated and confirmed by biochemical tests at the department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, for a period of three years were included in the study. The antimicrobial susceptibility tests of isolated organisms were performed by standard disc diffusion method as recommended by NCCLS. In addition to nitrofurantoin (NIT), doxycycline (DOX), co-trimoxazole (COT), ampicillin (AMP), imipenem (IPM) and vancomycin (VAN) were used for antimicrobial susceptibility testing.
RESULTS: One hundred and twenty seven (88%) isolates of Enterococci were susceptible to NIT while 72% (n = 103) to AMP, 13% to COT, 11% to DOX, 91% to IPM and 99% to VAN. Among the strains resistant to AMP, COT, DOX, IPM and VAN, 50-88% were susceptible to NIT.
CONCLUSION: Nitrofurantoin is an effective antimicrobial in vitro and can be used for treatment of Enterococcus urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518369

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  4 in total

1.  Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model.

Authors:  Iain J Abbott; Elke van Gorp; Aart van der Meijden; Rixt A Wijma; Joseph Meletiadis; Jason A Roberts; Johan W Mouton; Anton Y Peleg
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

2.  Prevalence and Antimicrobial Resistance of Enterococci Isolated from Retail Meats in the United States, 2002 to 2014.

Authors:  Gregory H Tyson; Epiphanie Nyirabahizi; Emily Crarey; Claudine Kabera; Claudia Lam; Crystal Rice-Trujillo; Patrick F McDermott; Heather Tate
Journal:  Appl Environ Microbiol       Date:  2017-12-15       Impact factor: 4.792

3.  Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India.

Authors:  Tuhina Banerjee; Shampa Anupurba
Journal:  Indian J Med Res       Date:  2016-10       Impact factor: 2.375

4.  Assessment of Nitrofurantoin as an Experimental Intracanal Medicament in Endodontics.

Authors:  Mewan Salahalddin A Alrahman; Bestoon Muhammed Faraj; Kawa F Dizaye
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.